MIRA — MIRA Pharmaceuticals, Inc.
Healthcare • Drug Manufacturers - General
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC)...…
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $1.48
- Day High
- $1.50
- Day Low
- $1.44
- 52w High
- $2.45
- 52w Low
- $0.73
- Volume
- 160,142
- Avg Volume
- Beta
- 1.813
* TTM/most recent where available
Company
- Ticker
- MIRA
- Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- US
- CEO
- Erez Aminov
- Employees
- 2
- Website
- mirapharmaceuticals.com
Key Metrics
- Market Cap
- 61.1M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).